Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01480336 · ClinicalTrials.gov registry record · NA
The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot
A NA study, sponsored by Hartford Hospital.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01480336 is a NA study that has completed, run by Hartford Hospital. The registered enrollment target is 19 participants.
The verdict
NCT01480336, a NA study, has completed, sponsored by Hartford Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to learn if combination therapy with amiodarone and ranolazine (an approved drug for chest pain) can help prevent arrhythmias.
Interventions
- DRUG Amiodarone Plus Ranolazine
- DRUG Amiodarone with Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2011-02 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01480336
The ClinicalTrials.gov registry entry for NCT01480336 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hartford Hospital, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Amiodarone Plus Ranolazine is the first listed.
NCT01480336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01480336 about?
NCT01480336 is a clinical study titled "The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot". The purpose of this study is to learn if combination therapy with amiodarone and ranolazine (an approved drug for chest pain) can help prevent arrhythmias.
What is the current status of trial NCT01480336?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2011-02. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01480336?
The interventions under investigation include: Amiodarone Plus Ranolazine (DRUG), Amiodarone with Placebo (DRUG).
Who is sponsoring clinical trial NCT01480336?
This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.